Publication | Closed Access

Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women

VaccinationVaccine SafetyHuman Papillomavirus VaccinesImmunologyVaccine TestingVirologyDose-ranging StudiesType 16Polyvalent VaccineMedicineVaccine ResearchEpidemiologyYoung Healthy Women